These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1464408)

  • 1. Glucogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo.
    Sánchez-Margalet V; Calvo JR; Goberna R
    Horm Metab Res; 1992 Oct; 24(10):455-7. PubMed ID: 1464408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.
    Sánchez-Margalet V; Calvo JR; Lucas M; Goberna R
    Gen Pharmacol; 1992 Jul; 23(4):637-8. PubMed ID: 1397969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogenolytic effect of pancreastatin in the rat.
    Sanchez V; Calvo JR; Goberna R
    Biosci Rep; 1990 Feb; 10(1):87-91. PubMed ID: 2187544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas.
    Funakoshi A; Miyasaka K; Kitani K; Tamamura H; Funakoshi S; Yajima H
    Biochem Biophys Res Commun; 1989 Feb; 158(3):844-9. PubMed ID: 2645871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin and pancreastatin inhibit stimulated insulin secretion in the mouse: comparison of effects.
    Lindskog S; Ahrén B
    Horm Res; 1988; 29(5-6):237-40. PubMed ID: 2464535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreastatin (33-49) enhances the priming effect of glucose in the rat pancreas.
    Sánchez-Margalet V; Goberna R
    Experientia; 1993 Jul; 49(6-7):551-2. PubMed ID: 8335081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pancreastatin on pancreatic endocrine function in the conscious rat.
    Funakoshi A; Miyasaka K; Kitani K; Tatemoto K
    Regul Pept; 1989 Mar; 24(3):225-31. PubMed ID: 2652201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreas.
    Silvestre RA; Peiró E; Miralles P; Villanueva ML; Marco J
    Life Sci; 1988; 42(14):1361-7. PubMed ID: 2895408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivity of human pancreastatin and its localization in pancreas.
    Funakoshi A; Jimi A; Yasunami Y; Tateishi K; Funakoshi S; Tamamura H; Yajima H
    Biochem Biophys Res Commun; 1989 Mar; 159(3):913-8. PubMed ID: 2649103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice.
    Ahrén B; Lindskog S; Tatemoto K; Efendić S
    Diabetes; 1988 Mar; 37(3):281-5. PubMed ID: 3286328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats.
    Miyasaka K; Funakoshi A; Yasunami Y; Nakamura R; Kitani K; Tamamura H; Funakoshi S; Fujii N
    Regul Pept; 1990 Apr; 28(2):189-98. PubMed ID: 1693005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and glucagon releasing activity of coleonol (forskolin) and its effect on blood glucose level in normal and alloxan diabetic rats.
    Ahmad F; Khan MM; Rastogi AK; Kidwai JR
    Acta Diabetol Lat; 1991; 28(1):71-7. PubMed ID: 1650516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous pancreastatin inhibits insulin secretion without affecting glucagon and somatostatin release in the perfused rat pancreas.
    Peiró E; Dégano P; Miralles P; Silvestre RA; Marco J
    Regul Pept; 1991 Jul; 34(3):159-67. PubMed ID: 1681569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food deprivation alters liver glycogen metabolism and endocrine responses to hemorrhage.
    Ljungqvist O; Boija PO; Esahili H; Larsson M; Ware J
    Am J Physiol; 1990 Nov; 259(5 Pt 1):E692-8. PubMed ID: 2240208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas.
    Peiró E; Miralles P; Silvestre RA; Villanueva ML; Marco J
    Metabolism; 1989 Jul; 38(7):679-82. PubMed ID: 2661967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of porcine pancreastatin on endocrine function of canine pancreas.
    Ohneda A; Koizumi F; Ohneda M
    Tohoku J Exp Med; 1989 Dec; 159(4):291-8. PubMed ID: 2699104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreastatin and islet hormone release.
    Efendić S; Tatemoto K; Mutt V; Quan C; Chang D; Ostenson CG
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7257-60. PubMed ID: 2890162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas.
    Holst JJ; Ostenson CG; Harling H; Messell T
    Diabetologia; 1990 Jul; 33(7):403-6. PubMed ID: 1976102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin suppression is associated with hypersomatostatinemia and hyperglucagonemia in glucose-injected rainbow trout.
    Harmon JS; Eilertson CD; Sheridan MA; Plisetskaya EM
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R609-13. PubMed ID: 1679608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes.
    Sánchez-Margalet V; Goberna R
    Regul Pept; 1994 May; 51(3):215-20. PubMed ID: 7938705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.